Stericycle Inc Stock Research

Market Summary

USD43.35-0.29

Market Closed

-0.66%

SRCL Alerts

Big jump in Earnings (Y/Y)

SRCL Stock Price

SRCL RSI Chart

SRCL Valuation

Market Cap

4.0B

Price/Earnings (Trailing)

48.91

Price/Sales (Trailing)

1.47

EV/EBITDA

18.41

Price/Free Cashflow

25.45

SRCL Price/Sales (Trailing)

SRCL Profitability

EBT Margin

2.92%

Return on Equity

2.33%

Return on Assets

1.06%

Free Cashflow Yield

3.93%

SRCL Fundamentals

SRCL Revenue

Revenue (TTM)

2.7B

Revenue Y/Y

3.03%

Revenue Q/Q

2.09%

SRCL Earnings

Earnings (TTM)

81.9M

Earnings Y/Y

180.14%

Earnings Q/Q

-64.8%

Price Action

52 Week Range

39.6356.12

(Low)(High)

Last 7 days

-0.8%

Last 30 days

2.6%

Last 90 days

-11.3%

Trailing 12 Months

-10.5%

SRCL Financial Health

Current Ratio

0.9

Debt/Equity

0.61

Debt/Cashflow

0.13

SRCL Investor Care

Shares Dilution (1Y)

0.43%

Diluted EPS (TTM)

0.88

Peers (Alternatives to Stericycle)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
WM	66.2B	19.9B	-1.84%	3.19%	29.3	3.32	7.84%	18.34%
CTAS	47.0B	8.6B	0.95%	25.29%	36.26	5.46	13.01%	7.22%
RSG	45.1B	14.1B	2.43%	7.15%	29.7	3.2	21.02%	12.77%
CPRT	41.2B	3.7B	10.07%	59.89%	38.09	11.22	16.24%	-0.79%
WCN	35.3B	7.5B	-3.49%	8.77%	41.39	4.73	16.63%	33.72%
MID-CAP
CLH	7.8B	5.3B	0.23%	62.03%	17.82	1.47	27.32%	93.47%
TTEK	7.3B	3.8B	-1.59%	9.53%	23.54	1.91	12.95%	25.10%
CWST	4.8B	1.1B	5.43%	33.09%	91.88	4.33	19.27%	27.96%
SRCL	4.0B	2.7B	2.58%	-10.51%	48.91	1.47	3.09%	222.06%
SMALL-CAP
HCCI	800.3M	763.4M	-5.53%	29.23%	9.44	1.05	38.98%	39.07%
PESI	148.8M	74.8M	35.08%	95.60%	-51.58	1.99	15.11%	-592.15%
AWX	10.7M	85.2M	-8.70%	-14.86%	-152.36	0.14	22.52%	-12062.50%
CHRA	7.3M	318.1M	-58.03%	-48.46%	-0.22	0.02	19.84%	22.30%

Financials for Stericycle

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	0.7%	2,725	2,705	2,692	2,650	2,643
Gross Profit	1.6%	1,042	1,026	1,018	992	1,000
S&GA Expenses	-2.5%	865	888	928	992	983
EBITDA	25.1%	260	208	106	122	-
EBITDA Margin	24.5%	0.10*	0.08*	0.04*	0.05*	-
Earnings Before Taxes	39.3%	110	79.00	32.00	-70.00	-50.50
EBT Margin	145.4%	0.03*	0.01*	-0.03*	-0.02*	-
Interest Expenses	6.6%	77.00	73.00	66.00	66.00	65.00
Net Income	45.0%	82.00	57.00	8.00	-85.90	-67.10
Net Income Margin	602.9%	0.02*	0.00*	-0.03*	-0.03*	-
Free Cahsflow	885.5%	68.00	7.00	8.00	72.00	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	0.0%	5,332	5,334	5,341	5,408	5,477
Current Assets	0.9%	564	559	598	597	614
Cash Equivalents	7.1%	60.00	56.00	44.00	46.00	60.00
Net PPE	-0.4%	713	716	712	720	713
Goodwill	0.1%	2,788	2,785	2,749	24.00	2,809
Liabilities	-0.8%	2,886	2,910	3,015	3,054	3,096
Current Liabilities	-6.7%	581	622	587	619	670
Long Term Debt	0.2%	1,487	1,484	1,652	1,676	1,678
Shareholder's Equity	1.0%	2,445	2,420	2,322	2,354	2,381
Retained Earnings	0.8%	1,422	1,411	1,379	1,351	1,341
Additional Paid-In Capital	0.3%	1,289	1,285	1,281	1,271	1,263
Accumulated Depreciation	2.9%	677	658	664	681	678
Shares Outstanding	0.2%	92.00	92.00	92.00	92.00	92.00
Minority Interest	-86.0%	1.00	4.00	3.00	4.00	4.00

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	44.1%	289	200	144	135	202
Share Based Compensation	8.4%	27.00	25.00	28.00	28.00	27.00
Cashflow From Investing	2.7%	-82.30	-84.60	-120	-99.30	-102
Cashflow From Financing	-82.0%	-202	-111	-8.00	-46.30	-88.40

Risks for SRCL

What is the probability of a big loss on SRCL?

86.9%

Probability that Stericycle stock will be more than 20% underwater in next one year

60.8%

Probability that Stericycle stock will be more than 30% underwater in next one year.

22.7%

Probability that Stericycle stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does SRCL drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Stericycle was unfortunately bought at previous high price.

Drawdowns

Returns for SRCL

Cumulative Returns on SRCL

-9.0%

10-Year Cumulative Returns

-10.9%

7-Year Cumulative Returns

-7.3%

5-Year Cumulative Returns

-5.3%

3-Year Cumulative Returns

What are the long-term rolling returns for SRCL?

FIve years rolling returns for Stericycle.

Annualized Returns

Which funds bought or sold SRCL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-22	AMERIPRISE FINANCIAL INC	reduced	-22.37	-4,800,740	10,133,300	-%
2023-05-18	SkyView Investment Advisors, LLC	added	17.33	11,000	453,000	0.11%
2023-05-18	JPMORGAN CHASE & CO	added	42.19	23,933,000	122,466,000	0.01%
2023-05-18	NEW YORK STATE COMMON RETIREMENT FUND	added	1.49	-559,000	4,399,000	0.01%
2023-05-17	Westside Investment Management, Inc.	unchanged	-	4,357	4,361	-%
2023-05-17	Advisory Services Network, LLC	reduced	-7.16	-60,002	258,346	0.01%
2023-05-17	KB FINANCIAL PARTNERS, LLC	added	16.03	5,000	413,000	0.12%
2023-05-17	Thrivent Financial for Lutherans	reduced	-0.92	-164,000	1,061,000	-%
2023-05-16	CASTLEARK MANAGEMENT LLC	reduced	-99.37	-6,050,510	33,580	-%
2023-05-16	SUSQUEHANNA INTERNATIONAL GROUP, LLP	reduced	-12.83	-64,784	207,366	-%

Latest Funds Activity

Are funds buying SRCL calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own SRCL

No. of Funds

SRCL Alerts

Big jump in Earnings (Y/Y)

Stericycle News

Schedule 13G FIlings of Stericycle

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	price t rowe associates inc /md/	4.9%	4,542,380	SC 13G/A
Feb 14, 2023	clarkston capital partners, llc	6.87%	6,332,330	SC 13G
Feb 14, 2023	alliancebernstein l.p.	7.6%	6,963,391	SC 13G/A
Feb 09, 2023	vanguard group inc	9.60%	8,845,201	SC 13G/A
Feb 08, 2023	black creek investment management inc.	5.59%	0	SC 13G
Feb 03, 2023	blackrock inc.	8.5%	7,803,191	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	12.0%	11,062,819	SC 13G/A
Feb 14, 2022	alliancebernstein l.p.	7.4%	6,841,439	SC 13G/A
Feb 10, 2022	vanguard group inc	9.10%	8,358,752	SC 13G/A
Feb 03, 2022	baillie gifford & co	4.72%	4,337,921	SC 13G/A

SRCL Fair Value

Stericycle fair value in different scenarios

The table shows the Fair Value estimates for Stericycle for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	18.60 -57.09%	24.16 -44.27%	29.38 -32.23%	34.40 -20.65%	40.84 -5.79%
Current Inflation	18.06 -58.34%	23.15 -46.60%	27.92 -35.59%	32.49 -25.05%	38.28 -11.70%
Very High Inflation	17.34 -60.00%	21.83 -49.64%	26.06 -39.88%	30.07 -30.63%	35.06 -19.12%

Historical Stericycle Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Stericycle

View All Filings

Date Filed	Form Type	Document
May 18, 2023	8-K	Current Report
May 17, 2023	3	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading
May 17, 2023	4	Insider Trading

Latest Insider Trading transactions for SRCL

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-01	Rogers Kurt	sold (taxes)	-192,813	45.55	-4,233	evp & general counsel
2023-05-01	Rogers Kurt	acquired	-	-	11,068	evp & general counsel
2023-04-14	Weisman Michael	acquired	-	-	333	evp corp ethics and compliance
2023-04-14	Weisman Michael	sold (taxes)	-4,116	42.00	-98.00	evp corp ethics and compliance
2023-04-01	Rogers Kurt	sold (taxes)	-109,374	43.61	-2,508	evp & general counsel
2023-04-01	Rogers Kurt	acquired	-	-	8,559	evp & general counsel
2023-03-15	Rogers Kurt	sold (taxes)	-33,314	42.82	-778	evp & general counsel
2023-03-15	White Stephen Cory	acquired	-	-	2,409	evp & chief commercial officer
2023-03-15	Weisman Michael	sold (taxes)	-19,397	42.82	-453	evp corp ethics and compliance
2023-03-15	Culotta Dominic	sold (taxes)	-22,609	42.82	-528	evp engineering

About Stericycle

Cindy J. Miller

www.stericycle.com

15000

Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names. It also provides secure information destruction services, including document and hard drive destruction services under the Shred-it brand; and communication solutions, such as appointment reminders, secure messaging, event registration, and other communications specifically for hospitals and integrated delivery networks. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was incorporated in 1989 and is headquartered in Bannockburn, Illinois.

SRCL Income Statement

2023-03-31

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues	$ 684.3	$ 664.2
Cost of revenues	423.3	419.7
Gross profit	261.0	244.5
Selling, general and administrative expenses	216.0	238.6
Divestiture losses, net	5.0	0.0
Income from operations	40.0	5.9
Interest expense, net	(20.4)	(16.3)
Other income (expense), net	0.2	(0.8)
Income (Loss) before income taxes	19.8	(11.2)
Income tax expense	(8.5)	(2.9)
Net income (loss)	11.3	(14.1)
Net income attributable to noncontrolling interests	(0.1)	(0.1)
Net income (loss) attributable to Stericycle, Inc. common shareholders	$ 11.2	$ (14.2)
Income (Loss) per common share attributable to Stericycle, Inc. common shareholders:
Basic (in dollars per share)	$ 0.12	$ (0.15)
Diluted (in dollars per share)	$ 0.12	$ (0.15)
Weighted average number of common shares outstanding:
Basic (in shares)	92.3	92.0
Diluted (in shares)	92.7	92.0

SRCL Balance Sheet

2023-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 60.0	$ 56.0
Accounts receivable, less allowance for doubtful accounts of $50.2 in 2023 and $53.3 in 2022	419.5	414.5
Prepaid expenses	34.7	33.2
Other current assets	49.5	55.0
Total Current Assets	563.7	558.7
Property, plant and equipment, less accumulated depreciation of $677.1 in 2023 and $657.7 in 2022	713.0	715.7
Operating lease right-of-use assets	414.7	398.9
Goodwill	2,787.8	2,784.9
Intangible assets, less accumulated amortization of $853.1 in 2023 and $823.3 in 2022	784.8	811.1
Other assets	68.0	64.8
Total Assets	5,332.0	5,334.1
Current Liabilities:
Current portion of long-term debt	16.2	22.3
Bank overdrafts	2.4	2.9
Accounts payable	195.3	213.5
Accrued liabilities	220.7	244.1
Operating lease liabilities	95.4	91.2
Other current liabilities	50.5	47.9
Total Current Liabilities	580.5	621.9
Long-term debt, net	1,486.5	1,484.0
Long-term operating lease liabilities	340.2	329.0
Deferred income taxes	431.8	427.0
Long-term income taxes payable	11.4	11.8
Other liabilities	35.6	35.9
Total Liabilities	2,886.0	2,909.6
Commitments and contingencies
EQUITY
Common stock (par value $0.01 per share, 120.0 shares authorized, 92.4 and 92.2 issued and outstanding in 2023 and 2022, respectively)	0.9	0.9
Additional paid-in capital	1,289.2	1,285.4
Retained earnings	1,422.0	1,410.8
Accumulated other comprehensive loss	(266.7)	(276.9)
Total Stericycle, Inc.’s Equity	2,445.4	2,420.2
Noncontrolling interests	0.6	4.3
Total Equity	2,446.0	2,424.5
Total Liabilities and Equity	$ 5,332.0	$ 5,334.1